Alterations of mtDNA copy number in gastric carcinoma

World Chinese Journal of Digestology

Volumn 12, Issue 2, 2004, Pages 258-261

  Han, Cheng Bo ^a   Li, Fan ^a   Yang, Xue Fei ^a   Mao, Xiao Yun ^a   Wu, Dong Ying ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; MITOCHONDRIAL DNA; TUMOR MARKER;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRECANCER; QUANTITATIVE ANALYSIS; SILVER STAINING; STOMACH CANCER; STOMACH CARCINOMA;

EID: 1942538396     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v12.i2.258     Document Type: Article

References (31)

1. Li YL, He XM, Zheng HC, Wu DY, Yang XF, Xin Y, Fu BY. Expression of PTEN encoding product in malignant lesions of gastric mucosa and its significance. Shijie Huaren Xiaohua Zazhi 2003;11:1294-1296
2. Yu Y, Zhang YC, Zhang WZ, Shen LS, Hertzog P, Wilson TJ, Xu DK. Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol 2003;9:2154-2159
3. phe and gastric carcinomas. World J Gastroenterol 2003;9:1925-1929
4. 44vg, MMP-2 and tumor invasion and metastasis in gastric cancer. Shijie Huaren Xiaohua Zazhi 2003;11:1531-1534
5. Feng RE, Chen J, Cui QC, Zhan Y, Wang ZY. Expression of PKC β1 and PKC β2 in early gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2003;11:1286-1289
6. Fu YG, Qu YJ, Wu KC, Zhai HH, Liu ZG, Fan DM. Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901. World J Gastroenterol 2003;9:1935-1939
7. Zhao XH, Gu SZ, Liu SX, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 2003;9:665-669
8. Huang HL, Wu BY, You WD, Shen MS. Prognostic factors and pathology of advanced gastric cancer. Shijie Huaren Xiaohua Zazhi 2003;11:1297-1301
9. Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, Xiao TL, Luo YH. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003;9:655-659
10. Li HX, Chang XM, Song ZJ, He SX. Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma. World J Gastroenterol 2003;9:674-677
11. Lan J, Xiong YY, Lin YX, Wang BC, Gong LL, Xu HS, Guo GS. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol 2003;9:54-58
12. Han CB, Li F, Xin Y. Advances in relationship between mitochondrial DNA and Peptic Tumor. Shijie Huaren Xiaohua Zazhi 2003;11:624-627
13. Raha S, Robinson BH. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 2001;106:62-70
14. Li JM, Cai Q, Zhou H, Xiao GX. Effects of hydrogen peroxide on mitochondrial gene expression of intestinal epithelial cells. World J Gastroenterol 2002;8:1117-1122
15. Xin Y, Li XL, Wang YP, Zhang SM, Zheng HC, Wu DY, Zhang YC. Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas. World J Gastroenterol 2001;7:53-59
16. Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer 2002;1:9
17. Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res 2001;488:9-23
18. Herrera B, Alvarez AM, Sanchez A, Fernandez M, Roncero C, Benito M, Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J 2001;15:741-751
19. Mandavilli BS, Santos JH, Van Houten B. Mitochondrial DNA repair and aging. Mutat Res 2002;509:127-151
20. Chung YM, Bae YS, Lee SY. Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 2003;34:434-442
21. Chomyn A, Attardi G. mtDNA Mutations in aging and apoptosis. Biochem Biophys Res Commun 2003;304:519-529
22. Yang L, Wang YP, Wu DY, Zhang SM, Li JY, Zhang YC, Xin Y. Pathological behaviors and molecular mechanisms of signet ring cell carcinoma and mucinous adenocarcinoma of stomach: a comparative study. Shijie Huaren Xiaohua Zazhi 2002;10:516-524
23. Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 2003;278:5493-5496
24. Li JM, Zhou H, Cai Q, Xiao GX. Role of mitochondrial dysfunction in hydrogen peroxide-induced apoptosis of intestinal epithelial cells. World J Gastroenterol 2003;9:562-567
25. Ogawa R, Streiff MB, Bugayenko A, Kato GJ. Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells. Blood 2002;99:3390-3397
26. Sarfati M, Mateo V, Baudet S, Rubio M, Fernandez C, Davi F, Binet JL, Delic J, Merle-Beral H. Sildenafil and vardenafil, types 5 and 6 phosphodiesterase in hibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. Blood 2003;101:265-269
27. Moon EY, Lerner A. PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 2003;101:4122-4130
28. Frame MJ, Tate R, Adams DR, Morgan KM, Houslay MD, Vandenabeele P, Pyne NJ. Interaction of caspase-3 with the cyclic GMP binding cyclic GMP specific phosphodiesterase (PDE5a1). Eur J Biochem 2003;270:962-970
29. Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, Pamukcu R. Exisulind induction of apoptosis involves guanosine 3′, 5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 2000;60:3338-3342
30. Huston M, Beard F, McCallum NJ, Pyne P, Vandenabeele GS, Houslay MD. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. J Biol Chem 2000;275:28063-28074
31. Gale DD, Landells LJ, Spina D, Miller AJ, Smith K, Nichols T, Rotshteyn Y, Tonelli A, Lacouture P, Burch RM, Page CP, O'Connor BJ. Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE) 4 inhibitor V11294A in healthy volunteers. Br J Clin Pharmacol 2002;54:478-484